# reload+after+2024-01-23 07:44:37.566791
address1§21925 W. Field Parkway
address2§Suite 235
city§Deer Park
state§IL
zip§60010-7208
country§United States
phone§847 787 7361
website§https://www.etonpharma.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
fullTimeEmployees§28
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Sean E. Brynjelsen', 'age': 51, 'title': 'President, CEO & Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 868126, 'exercisedValue': 0, 'unexercisedValue': 290000}, {'maxAge': 1, 'name': 'Mr. James R. Gruber CPA', 'age': 51, 'title': 'CFO, Treasurer & Secretary', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 457584, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David C. Krempa', 'age': 34, 'title': 'Chief Business Officer', 'yearBorn': 1989, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ingrid  Hoos', 'title': 'Senior Vice President of Regulatory Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin  Guthrie', 'title': 'Executive VP of Commercial Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.203
priceToSalesTrailing12Months§3.392252
currency§USD
dateShortInterest§1702598400
forwardEps§0.26
exchange§NGM
quoteType§EQUITY
shortName§Eton Pharmaceuticals, Inc.
longName§Eton Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1542119400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§fbcd977f-686a-3d1e-ae47-b3ae800e35f4
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§10.0
targetMeanPrice§10.0
targetMedianPrice§10.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§2.46
grossMargins§0.72473997
ebitdaMargins§0.08137
trailingPegRatio§None
